Elicit releases BioDecisionBench to evaluate AI reasoning in high-stakes drug development decisions
elicitorg · x · 2026-08-07
Elicit introduces BioDecisionBench, a benchmark with 40 task variants derived from 26 complex reasoning failures in life sciences, spanning the drug development process from target selection to clinical trial design. It aims to assess AI's reasoning ability in high-stakes decisions under ambiguity and limited information, going beyond final answers to evaluate the reasoning process, which existing benchmarks often overlook.
Related event: Elicit Introduces BioDecisionBench for AI Drug Discovery(3 posts)→
More from Research
- Multimodal Embeddings Reshape RAG: Ditch Lossy Text Conversion for Native Retrieval — CShorten30 · 2026-08-07
- Deep Dive: What Comes After Large Language Models? — bigdata · 2026-08-07
- Brown postdoc program expands with ARIA, a $20M NSF institute for trustworthy AI assistants — tserre · 2026-08-07
- Scholars Propose AI Pre-Review for Papers: Automated Code Replication and Error Checking — Afinetheorem · 2026-08-07
- Brown University postdoc fellowships in computational brain science, bridging AI and neuroscience — tserre · 2026-08-07
- Exploring Best Practices for Training WAN 2.2 Motion LoRAs — fluvialcrunchy · 2026-08-07